The effects of recombinant human (rh) interleukin (IL)-4 or rhIL-13 on survival, and chemotactic activity of human eosinophils were examined. Only rhIL-13 prolonged eosinophil survival in a dose-dependent manner above 3 ng/ml. Eosinophil survival induced by rhIL-13 was inhibited by monoclonal antibodies (mAbs) against IL-3 (p<0.0!) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (p<0.05), suggesting that rhIL-13 induced IL-3 and GM-CSF production from eosinophils and an autocrine mechanism is responsible for the eosinophil survival. The effects of rhIL-13 on eosinophil chemotactic activity were also examined. rhIL-13 showed chemotactic activity for eosinophils in a dose-dependent manner. Checkerboard analysis revealed that eosinophil migration was dependent on the concentration gradient, confirming that rhIL-13 is a chemotactic factor. rhIL-4 showed no effects. IL-13 may play an important role in the survival and recruitment of eosinophils in allergic diseases.
Introduction
Eosinophils play important roles as effector cells in allergic diseases including bronchial asthma (1) . To carry out their effector function at the site of inflammation, a series of events including eosinophil activation, adhesion and transmigration through endothelial cells, chemotaxis, and interaction with target cells such as bronchial epithelial cells are subtly regulated by various cytokines. The cytokines interleukin (IL) -5, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) participate in eosinophilopoesis and differentiation (2-A), prolonged eosinophil survival (5) , and enhancement of adhesion molecule CD1 la, CD1 lb, and CD18 expression (6) . In addition, these cytokines enhance (7) or directly induce (8) eosinophil degranulation or superoxide production. In addition, IL-4 has been shown to be involved in B cell proliferation and isotype switching (9) , and in IgE synthesis ( 1 0) . These cytokines have been referred to as Th2-like cytokines and have been reported in bronchoalveolar lavage fluid in patients with bronchial asthma ( 1 1) . A positive correlation was observed between Th2-like cytokines and the infiltration of EG2+ eosinophils and activated (CD25+) T lymphocytes ( 1 2) , suggesting that these molecules are responsible for the recruitment of eosinophils.
Furthermore, IL-4 is also involved in eosinophil recruitment by inducing vascular cell adhesion molecule-1 (VCAM-1) expression on endothelial cells (13) . However,the effects of IL-4 on the biological activities and/or effector functions of eosinophils have yet to be clarified, although some investigators have observed HLA-DRexpression on human eosinophils ( 14), or reduction of arylsulfatase and (3-glucuronidase secretion induced by IgG-coated Sepharose beads (15) when humaneosinophils were exposed to IL-4. Recently, a new T cell-derived cytokine IL-1 3, is reported to share approximately 30% structural homology with IL-4 and shows effects on B cells and monocytes was reported (16, 17) . However, the biological functions ofIL-1 3 on human eosinophils are uncertain. To determine whether recombinant human (rh)IL-13, as well as rhIL-4, exerts specific biological effects on normal human eosinophils, eosinophil survival, degranulation, and chemotactic activity were examined.
Materials and Methods

Reagen ts
The reagents employed in this study were as follows: rhlL-1 3 (R&D Systems, Minneapolis, MN); rhIL-4 (Genzyme Corp., Cambridge, MA); rhIL-5 (Genzyme); rhGM-CSF (Genzyme);
and platelet-activating factor (PAF) from BIOMOLResearch Laboratories (Plymouth Meeting, PA). These cytokines were diluted in phosphate-buffered saline (PBS) containing 0. 1% bovine serum albumin (BSA) (Sigma Chemical Co., St. Louis, MO)to 10 jug/ml and stored at -80°C. PAF was dissolved in absolute ethanol to 40 mMand stored at -20°C and then diluted in reaction mediumto the desired concentrations immediately before the experiments. Purified human IgG was purchased from Cappel-Organon Teknika Co. (Durham, NC) and dissolved in distilled water at a concentration of 1 mg/ml.
Eosinophil isolation
Eosinophil isolation was performed essentially by the method described by Hansel et al with minor modifications using a magnetic cell separation system (Becton Dickinson, Lincoln Park, NJ) (1 8) . Briefly, heparinized venous blood was obtained from normal volunteers and diluted with PIPES buffer (25mM PIPES/50mM NaCl/5mM KCl/25mM NaOH/5.4mM glucose, pH 7.4) ataratioof 1 : 1. Dilutedbloodwas layeredoverisotonic Percoll solution (density 1.082 g/ml) (Sigma Chemical Co., St. Louis, MO) and centrifuged at l,000xg for 30 minutes at 4°C. The supernatants and mononuclear cells at the interface were carefully removed, and erythrocytes in the sediment were lysed by two cycles of hypotonic lysis in distilled water. Isolated granulocytes were washedtwice with PIPESbuffer supplemented with 1 % inactivated fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT), and an approximately equal volume ofanti-CD 16 monoclonal Ab (mAb) conjugated with magnetic particles (Militenyi Biotec GmbH, Sunnyvale, CA) was added to the cell pellet. After 60 minutes of incubation on ice, 5ml of PIPES containing 1 %FBS was added to the cell/mAb mixture. Resuspended cells were loaded onto the separation column positioned in the magneticcell separation system's strong magnetic field. Cells were eluted three times with 5ml PIPES buffer containing 1 % FBS. The purity ofeosinophils as counted using Randolph's stain was >98%.Purified eosinophils were washed twice with PIPES buffer containing 1% FBS and suspendedin reaction medium.
Eosinophil survival assay
Purified eosinophils were suspended in Hybri-Care medium (American Type Culture Collection, Rockville, MD), supplemented with 50 jLtg/ml gentamicin (Sigma), 0. 1 %Human serum albumin (HSA) (Sigma, A3782), 1.5 g// NaHCO3, and 10% FBS, (Hybri-Care complete medium) at a cell concentration of 0.2x106/ml. Fifty jul aliquots of eosinophil suspension were incubated with 50 Jill of cytokine solution diluted in the same medium for4 days at 37°C and 5% CO2 in 96-well half area flatbottomed tissue culture plates (#3696, Coaster, Cambridge, MA). After incubation, 50 \i\ of supernatant was carefully removed from each well and 10 jLtl of fluorescent diacetate in DNA fragmentation assay DNAfragmentation assay was performed using a Cell Death Detection Kit ELISA (Boehringer Manheim, Germany). One ml of purified eosinophil suspension in Hybri-Care complete mediumat a concentration of 0. 1xlO6 cells/ml was cultured in the presence or absence ofcytokines at 37°C and 5%CO2for 2 days. After incubation, cell suspensions were centrifuged at 500xg for 5 minutes, and supernatants were carefully removed. Cell pellets were lysed with 500 jllI of the incubation buffer provided by manufacturer for 30 minutes at 4°C. The lysates were then centrifuged at 20,000xg for 10 minutes, and 400 jul of supernatants containing the fragmented DNAwere carefully collected and stored at -20°C until assayed. Fragmented DNA was determined by the sandwich ELISAmethod from absorbance at 405 nmwith a reference wavelength of 492 nm.
Measurementof eosinophil chemotactic activity
To examine the effect of rhIL-13 or human rhIL-4 on eosinophil chemotactic activity, purified eosinophils were suspended in Hanks' balanced salt solution (HBSS) with 2% BSA at a concentration of 2x106 cells/ml. The chemotaxis assay was performed in 48 -well microchemotaxis chambers (Neuroprobe, Cabin John, MD)as described elsewhere (19). The bottom wells of the chambers were filled with 25 jul ofHBSScontaining various concentrations ofrhIL-1 3 or rhIL-4, and then they were covered with polycarbonate filters with a pore size of 5 |um (Nucleopore Corp., Pleasanton, CA). The silicon gasket and upper piece of the chamberwere applied, and upper wells were filled with 50 jul of eosinophil suspension. The chambers were incubated in humidified air at 37°C for 3 hours. After incubation, the chamberswere disassembled, and the filters were removed. The filters were then fixed, stained with Diff-Quik (American Scientific Products, McGraw Park, IL), and mounted on glass slides. Eosinophils which completely migrated through the filter were counted in five random high-power fields (x 1 ,000) per well. plates (Falcon #3072, Becton-Dickinson, Lincoln Park, NJ) were coated with 5 [ig of purified human IgG which is the optimal dose for induction of eosinophil degranulation at 37°C overnight. The plates were then washed with PBSthree times and wells were blockedby 50 \i\ of2.5% HSA dissolved in PBS (pH 7.4) at 37°C for 2 hours. For eosinophil degranulation induced by soluble stimuli, PAF and rhGM-CSF, 96-well flatbottomed tissue culture plates were coated with 50 jul of 2.5% HSAat 37°C for 2 hours to avoid nonspecific degranulation (1 1) . The purity of the HSAwas certified by manufacturer, and the product was globulin-free. After blocking with HSA, wells were washed three times with PBS and stored at 4°C until use. Freshly isolated eosinophils were washed twice with RPMI 1,640 medium (RPMI 1,640, 1.5 g// NaHCO3 and 10 mM HEPES(Sigma), pH 7.2), and resuspended in the same medium at 5xl05 cells/ml. The soluble stimuli were also diluted in the same medium. Subsequently, 1 00 jul aliquots of cell suspension were added onto the HSA-coated tissue culture plates, and incubated with 50 pi aliquots of rhIL-13 or rhIL-4 for 10 minutes before adding stimuli or mediumalone. Eosinophil degranulation was initiated by adding 50 |il of rhGM-CSF or PAF at final concentrations of 10 ng/ml and 1 jllM, respectively. After incubation at 37°C in a 5% CO2atmosphere for 4 hours, the supernatants from wells were collected carefully and kept at -20°C until assayed. All experiments were carried out in duplicate. To monitor eosinophil degranulation, concentrations ofeosinophil protein X (EPX) usually referred to as EDNin the sample supernatants were measured by radioimmunoassay using an EPX kit (Kabi Pharmacia Diagnostics, Tokyo, Japan). To measure the total content of EPX, eosinophils were lysed with 0.5% Nonnidet P-40 (NP-40). All assays were carried out in duplicate.
Statistical analysis Statistical significance of the differences between various treatment groups was assessed with paired Student's t-test.
Results and Discussion rhlL-13 prolongs eosinophil survival Weexamined the effect ofrhIL-1 3 on eosinophil survival. In the absence ofcytokines such as IL-3, IL-5, or GM-CSF,most eosinophils die within 96 hours (5) . As shown in Fig. 1 , the survival of the eosinophils cultured with rhIL-1 3 for 4 days was significantly prolonged at 3 ng/ml and was enhanced in a dosedependent manner; 50% survival was achieved at 100 ng/ml, and more than 80%of eosinophils were viable at a concentration of 500 ng/ml. Although rhIL-13 showed prolonged eosinophil survival at high concentrations, rhIL-4 did not prolong the same mechanisms may be involved in the rhIL-13-induced eosinophil survival, DNAfragmentation assay was performed.
As shownin Fig. 3a , eosinophils cultured with mediumalone, or rhIL-4 showed less viability on day 2 compared with the viability of human rhIL-13. Therefore, DNAfragmentation assay was carried out on day 2. The absorbance of the lysates of freshly isolated eosinophils was less than 0.0 1. When eosinophils were cultured for 2 days with rhIL-4, rhIL-1 3, or mediumalone, eosinophils cultured with rhIL-1 3 at concentrations of 100 ng/ ml and 250 ng/ml showed significantly lower absorbance values, suggesting less fragmentation ofDNA (Fig. 3b) . On the other hand, rhIL-4 did not inhibit DNAfragmentation. These results show that rhIL-13-induced eosinophil survival is dependent on the inhibition of apoptosis.
Eosinophilsurvival
induced by rhIL-13 was inhibited by mAb against IL-3 and GM-CSF For prolongation of eosinophil survival, extremely high doses of rhIL-13 were required. The effect of 100 ng/ml rhlL-13 was almost equivalent to that of 1 pg/ml rhGM-CSF, or 10 pg/ml rhIL-5. This leads to the question of whether rhIL-13 prolongs eosinophil survival directly or through induction of release of other cytokines from eosinophils. It is well known that eosinophils are capable of producing cytokines such as IL-3, GM-CSF, and transforming growth factor-(3, in the peripheral blood obtained from patients with eosinophilia (22). Furthermore, calcium ionophores and adhesion of eosinophils to the extracellular matrix protein fibronectin also induce IL-3 and GM-CSFproduction by eosinophils (23, 24) . Production of these cytokines particularly IL-3 and GM-CSF,by eosinophils can prolong their survival by autocrine or paracrine mechanisms.
To analyze the mechanisms of rhIL-1 3-induced eosinophil survival, concentrations of IL-3, IL-5, and GM-CSFin the culture supernatant were measured by ELISA. As these cytokines were below the detectable range (data not shown), a more Eosinophil Survival and Chemotaxis by IL-1 3 sensitive bioassay using specific mAb was carried out.
Eosinophils were incubated with rhIL-13 (250 ng/ml) in the presence of 10 jig ofmAb against IL-3, IL-5, or GM-CSFfor 4 days (Fig. 4) . rhIL-1 3-induced eosinophil survival was significantly inhibited by anti-IL-3 (p<0.01) and anti-GM-CSF mAbs (p<0.05), while the anti-IL-5 mAbshowed no effect. Combination of anti-IL-3 and anti-GM-CSF mAbs showed further inhibition of eosinophil survival compared with anti-IL3 mAb alone or anti-GM-CSFalone. These results suggest that rhIL-1 3 prolongs eosinophil survival through an autocrine mechanism. Furthermore, IL-3 production from eosinophils may play the main role in rhIL-1 3-evoked eosinophil survival, and GM-CSF production may also be partially involved. Combination of the three mAbswas still insufficient to inhibit eosinophil survival to the baseline which was given by mediumalone. These results imply the involvement of other eosinophil survival-enhancing factors. The present results, however clearly showed that IL-3 and GM-CSFproduction and/or release from eosinophils induced by rhIL-13 are responsible for prolonged eosinophil survival.
rhIL-13 is a novel chemotactic factor for eosinophils The effect ofrhIL-1 3 on eosinophil chemotactic activity was examined. As shown in Fig. 5 , rhIL-1 3 induced obvious chemotactic activity when it was added to the lower compartment of the chambers at a concentration of 30 ng/ml; this activity |^^BIB^^BBiBBi^BBBBB^BBBIII^B~y~^i  0  20  40  60  80  100 Eosinophil survival (%) Figure 4 . Blocking of rhIL-13-induced eosinophil survival by mAbsagainst cytokines. Purified eosinophils were cultured with rhIL-13 (250 ng/ml) in the presence ofmAbs against IL-3, IL-5, GM-CSF, or various combinations of these mAbs.The results are presented as mean±SEM from three experiments performed in duplicate.
Significant differences are **p<0.01 and *p<0.05 from values obtained without mAb. increased in a dose-dependent manner and reached a plateau at 1 25 ng/ml. On the other hand, rhIL-4 did not induce chemotaxis of eosinophils. Checkerboard analysis revealed that rhIL-13 enhanced eosinophil migration along a concentration gradient, suggesting that rhIL-13 is a chemotactic factor for eosinophils (Table 1) . Thus, IL-13 is clearly a new cytokine with chemotaxis inducing activity foreosinophils similar to PAF, leukotriene B4, C5a, IL-5, and RANTES.
Effect of rhIL-13 on eosinophil degranulation Degranulation is one of the most important eosinophil effector functions. Our previous study showed that rhGM-CSF, rhIL-5, and PAF induce eosinophil degranulation by themselves (8) . Weexamined the effects ofrhIL-1 3 on the eosinophil degranulation induced by rhGM-CSF, PAF, and immobilized IgG. As shown in Fig. 6 , neither rhIL-13 nor rhIL-4 affected eosinophil degranulation in response to these stimuli. Immunohistochemically, infiltration of CD4+T cells and eosinophils is characteristic of allergic diseases. Analysis of the cytokines in nasal mucosa after local allergen provocation or in the bronchoalveolar lavage fluid from patients with bronchial asthma indicated predominant Th2-like cytokines such as IL-5, IL-4, IL-3, and GM-CSFat both protein and mRNAexpression levels (1 1, 25) . The late phase reaction of bronchial asthma is characterized by the effector function of activated eosinophils, and IL-5 is now widely accepted to play major roles in the infiltration and activation ofeosinophils (26). Furthermore, Th-2 type cytokines are also highly involved in the immediate allergic response through IL-4-induced IgE synthesis by B cells (10) . IL-13 has also been reported to induce IgE synthesis by B cells and to stimulate B cell proliferation (16).
However, the roles of IL-13 and IL-4 in the biological functions of eosinophils are not clear. Previous studies showed that IL-4 induces HLA-DR expression (14), and inhibits the Ig- In the last decade, the mechanisms of eosinophil recruitment into the sites of inflammation have been investigated. Various adhesion molecules including (32 integrins (CDl lb/CD18 or CD 1 la/CD1 8) and pl integrin (CD49d/CD29: VLA-4 orCD49f/ CD29: VLA-6) on the eosinophils are involved in eosinophil adhesion to endothelial cells (27) and in their transmigration (28). As ligands for integrins, intercellular adhesion molecule-1 (ICAM-1) and/or VCAM-1 expressed on the endothelial cells also play important roles. The expression of ICAM-1 and VCAM-1 is regulated by cytokines such as IL-lp, tumor necrosis factor (TNF)-oc, and IL-4. Among them, IL-4 is a unique cytokine because it enhances only VCAM-1 expression (13) . The counter-receptor of VCAM-1is VLA-4, which is expressed on eosinophils but not on neutrophils. For this reason, the role of IL-4 in eosinophil recruitment seems to be important. Recently, it was shown that rhIL-1 3 also selectively induces VCAM-1 expression on human endothelial cells (29). Interestingly, rhIL-13 did not induce neutrophil chemotaxis (manuscript in preparation), suggesting IL-1 3 may participate in selective eosinophil recruitment by affecting both endothelial cells and eosinophils in the allergic response. However, a question was raised regarding the concentration of rhIL-13 employed in this study. To obtain 50%survival on day 4, 100 ng/ml rhIL-13 was required. Also, 50% chemotactic activity was observed at 100 ng/ml. The concentration required for eosinophil survival by IL-13 was more than 10,000-fold by IL-5 or GM-CSF. Although the amount ofIL-13 in biological fluid such as bronchoalveolar lavage fluid from patients with bronchial asthma has not been precisely reported to date, it seems to be extremely high. However, in allergic diseases, IL-13 may participate in the activation and'recruitment of eosinophils in cooperation with other cytokines. In such conditions, much smaller amount ofIL-1 3 may act effectively. For example, it has been reported that IL-4 did not show chemotactic activity for normal human eosinophils; however, it is a potent chemoattractant for eosinophils from patients with atopic dermatitis (30).
In the present study, it was shown that rhIL-1 3rfout not rhlL-4 prolonged survival of normal human eosinophils and induced eosinophil chemotaxis. Furthermore, it was suggested that high doses ofrhIL-1 3 induce the production ofIL-3 and GM-CSFby eosinophils.
